News for Marinus Pharmaceuticals Stock (MRNS)

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Marinus Pharmaceuticals, Inc. (MRNS)

GlobeNewsWire • 06/06/24

The Schall Law Firm Initiates Investigation Into Allegations Against Marinus Pharmaceuticals, Inc. And Urges Investors Who Have Incurred Losses To Reach Out

Accesswire • 06/06/24

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Marinus Pharmaceuticals, Inc. - MRNS

GlobeNewsWire • 06/06/24

Class Action Lawsuit Filed on Behalf of Marinus Pharmaceuticals, Inc. (MRNS) Investors – Nationally Ranked Investors' Rights Firm Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

GlobeNewsWire • 06/06/24

Stockholder Alert: Robbins LLP Informs Investors that a Shareholder Has Filed a Class Action Against Marinus Pharmaceuticals, Inc. (MRNS)

GlobeNewsWire • 06/06/24

MRNS INVESTOR NEWS: ROSEN, A LEADING LAW FIRM, Encourages Marinus Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – MRNS

GlobeNewsWire • 06/06/24

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Marinus Pharmaceuticals, Inc. Investors – MRNS

Business Wire • 06/05/24

The Schall Law Firm Begins Probe Into Claims Against Marinus Pharmaceuticals, Inc. And Encourages Investors With Losses To Make Contact

Accesswire • 06/05/24

The Schall Law Firm Initiates Investigation into Allegations Against Marinus Pharmaceuticals, Inc. and Urges Investors with Losses to Reach Out

Accesswire • 06/04/24

MRNS ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 06/03/24

IMPORTANT ACTION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 06/02/24

IMPORTANT ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 06/01/24

IMPORTANT ACTION UPDATE: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 05/31/24

IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 05/30/24

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 05/19/24

IMPORTANT SHAREHOLDER INVESTIGATION: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 05/17/24

Here's Why Marinus Pharmaceuticals (MRNS) is Poised for a Turnaround After Losing -7.8% in 4 Weeks

Zacks Investment Research • 05/17/24

Marinus Pharmaceuticals Announces Key Business Updates for Tuberous Sclerosis Complex Program

Business Wire • 05/17/24

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 05/16/24

After Plunging -7.64% in 4 Weeks, Here's Why the Trend Might Reverse for Marinus Pharmaceuticals (MRNS)

Zacks Investment Research • 05/16/24

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 05/15/24

Marinus Pharmaceuticals (MRNS) Reports Q1 Loss, Lags Revenue Estimates

Zacks Investment Research • 05/08/24

Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results

Business Wire • 05/08/24

Marinus Pharmaceuticals to Present at the RBC Capital Markets 2024 Global Healthcare Conference

Business Wire • 05/02/24

Marinus Pharmaceuticals to Provide Business Update and Report First Quarter 2024 Financial Results on May 8, 2024

Business Wire • 05/01/24